PureTech Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4.66	4.83	3.33	15.62	17.39
Revenue Growth (YoY)	-3.50%	44.98%	-78.68%	-10.18%	47.76%
Cost of Revenue	-	69.23	94.98	152.43	110.47
Gross Profit	4.66	-64.4	-91.65	-136.82	-93.08
Selling, General & Admin	46.62	71.47	53.3	60.99	57.2
Research & Development	56.57	-	-	-	-
Operating Expenses	103.19	71.47	53.3	60.99	57.2
Operating Income	-98.53	-135.87	-144.94	-197.81	-150.28
Interest Expense	-45.78	-10.04	-13.49	-3.95	-4.71
Interest & Investment Income	-	22.67	16.01	5.8	0.21
Earnings From Equity Investments	-17.93	-8.75	-6.06	-27.75	-73.7
Currency Exchange Gain (Loss)	-	-0.03	-0.09	0.01	-0.06
Other Non Operating Income (Expenses)	14.38	-7.15	1.74	145.19	11.2
EBT Excluding Unusual Items	-147.86	-139.16	-146.82	-78.5	-217.34
Gain (Loss) on Sale of Investments	36.93	11.08	50.19	-41.53	158.39
Gain (Loss) on Sale of Assets	-	151.81	61.79	27.25	-
Asset Writedown	-	-0.23	-1.26	-	-
Other Unusual Items	-	0.27	-	-	-
Pretax Income	-110.93	23.77	-36.1	-92.78	-58.95
Income Tax Expense	-0.84	-4.01	30.53	-55.72	3.76
Earnings From Continuing Operations	-110.08	27.78	-66.63	-37.06	-62.71
Minority Interest in Earnings	0.35	25.73	0.93	-13.29	2.15
Net Income	-109.74	53.51	-65.7	-50.35	-60.56
Net Income to Common	-109.74	53.51	-65.7	-50.35	-60.56
Shares Outstanding (Basic)	239	254	276	285	287
Shares Outstanding (Diluted)	239	256	276	285	287
Shares Change (YoY)	-6.82%	-7.34%	-2.97%	-0.64%	-2.14%
EPS (Basic)	-0.46	0.21	-0.24	-0.18	-0.21
EPS (Diluted)	-0.46	0.21	-0.24	-0.18	-0.21
Free Cash Flow	-85.14	-134.38	-105.99	-180.97	-163.85
Free Cash Flow Per Share	-0.36	-0.53	-0.38	-0.64	-0.57
Gross Margin	100.00%	-	-	-	-
Operating Margin	-2114.75%	-2814.19%	-4352.55%	-1266.53%	-864.29%
Profit Margin	-2355.42%	1108.33%	-1972.88%	-322.41%	-348.27%
Free Cash Flow Margin	-1827.37%	-2783.35%	-3182.79%	-1158.71%	-942.29%
EBITDA	-95.18	-134.06	-141.99	-191.96	-145.93
D&A For EBITDA	3.35	1.81	2.95	5.85	4.35
EBIT	-98.53	-135.87	-144.94	-197.81	-150.28
Revenue as Reported	4.66	4.83	3.33	15.62	17.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.